Predicting Neurofibromatosis Type 1 Risk among Children with Isolated Café-au-lait macules
Overview
Authors
Affiliations
Background: Although isolated cafe-au-lait macules (CALMs) are a common skin finding, they are an early feature of neurofibromatosis type 1 (NF1).
Objective: We sought to develop an algorithm determining the risk of children with CALMs to have constitutional NF1.
Methods: We conducted a retrospective study of patients with isolated CALMs. Diagnosis of NF1 was based on detecting NF1 mutation in blood or fulfilling clinical criteria.
Results: In all, 170 of 419 (41%) and 21 of 86 (24%) children with isolated CALMs who underwent molecular testing and clinical follow-up, respectively, were given a diagnosis of NF1. Presence of fewer than 6 CALMs at presentation or atypical CALMs was associated with not having NF1 (P < .001). An algorithm based on age, CALMs number, and presence of atypical macules predicted NF1 in both cohorts. According to the algorithm, children older than 29 months with at least 1 atypical CALM or less than 6 CALMs have a 0.9% (95% confidence interval 0%-2.6%) risk for constitutional NF1 whereas children younger than 29 months with 6 or more CALMs have a high risk (80.4%, 95% confidence interval 74.6%-86.2%).
Limitations: The study was designed to detect constitutional NF1 and not NF1 in mosaic form.
Conclusions: A simple algorithm enables categorization of children with isolated CALMs as being at low or high risk for having NF1.
Veres K, Nagy B, Ember Z, Bene J, Hadzsiev K, Medvecz M Biomedicines. 2025; 13(1).
PMID: 39857730 PMC: 11762399. DOI: 10.3390/biomedicines13010146.
A Comprehensive Overview of NF1 Mutations in Iranian Patients.
Savad S, Modarressi M, Younesi S, Seifi-Alan M, Samadaian N, Masoomy M Neuromolecular Med. 2024; 26(1):28.
PMID: 38954284 DOI: 10.1007/s12017-024-08790-5.
Kehrer-Sawatzki H, Cooper D Hum Genet. 2021; 141(2):177-191.
PMID: 34928431 PMC: 8807470. DOI: 10.1007/s00439-021-02410-z.
Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.
Wang W, Wei C, Cui X, Li Y, Gu Y, Gu B Front Neurol. 2021; 12:704639.
PMID: 34566848 PMC: 8455870. DOI: 10.3389/fneur.2021.704639.
Karwacki M, Wysocki M, Perek-Polnik M, Jatczak-Gaca A Arch Med Sci. 2021; 17(5):1221-1231.
PMID: 34522251 PMC: 8425254. DOI: 10.5114/aoms.2019.85143.